Aerovate Therapeutics Inc (AVTE)

Dec 20, 2024

STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerAVTE, BCOV, ALVR, AE - cnhinews.com

Dec 20, 2024

Dec 19, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - Defense World

Dec 19, 2024

Dec 17, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 5.3% in November - MarketBeat

Dec 17, 2024

Dec 16, 2024

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - The Eastern Progress Online

Dec 16, 2024

Dec 16, 2024

Verition Fund Management LLC Sells 149,137 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Dec 16, 2024

Dec 13, 2024

Pulmonary Arterial Hypertension Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen Pharma, Aerovate - The Globe and Mail

Dec 13, 2024

Dec 06, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, PFIE, EMKR on Behalf of Shareholders - GlobeNewswire Inc.

Dec 06, 2024

Dec 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Dec 04, 2024

Nov 22, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE an - GuruFocus.com

Nov 22, 2024

Nov 17, 2024

GSA Capital Partners LLP Has $865,000 Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Declines By 17.3% - MarketBeat

Nov 16, 2024

Nov 16, 2024

Wedbush Research Analysts Raise Earnings Estimates for AVTE - Defense World

Nov 16, 2024

Nov 15, 2024

What is Wedbush's Forecast for AVTE FY2024 Earnings? - MarketBeat

Nov 15, 2024

Nov 12, 2024

Aerovate Therapeutics Reports Q3 Loss Amid Strategic Shift - TipRanks

Nov 12, 2024

Nov 08, 2024

Finansavisen - Finansavisen

Nov 08, 2024

Nov 06, 2024

Jade Biosciences’ Merger with Aerovate Therapeutics - Global Legal Chronicle

Nov 06, 2024

Nov 05, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders - Marketscreener.com

Nov 05, 2024

Nov 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com

Nov 04, 2024

Nov 04, 2024

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com

Nov 04, 2024

Nov 02, 2024

Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World

Nov 02, 2024

Nov 01, 2024

How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury

Nov 01, 2024

Nov 01, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com

Nov 01, 2024

Nov 01, 2024

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve

Nov 01, 2024

Oct 31, 2024

SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow

Oct 31, 2024

Oct 31, 2024

Form 425 Aerovate Therapeutics, Filed by: Aerovate Therapeutics, Inc. - StreetInsider.com

Oct 31, 2024

Oct 31, 2024

Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph

Oct 31, 2024

Oct 31, 2024

Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive

Oct 31, 2024

Oct 31, 2024

Jade Biosciences and Aerovate announce merger deal - Investing.com

Oct 31, 2024

Oct 31, 2024

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Oct 31, 2024

Oct 31, 2024

Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch

Oct 31, 2024

Oct 31, 2024

Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Oct 31, 2024

Oct 31, 2024

Aerovate climbs on all-stock merger deal with Jade - MSN

Oct 31, 2024

Oct 31, 2024

Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha

Oct 31, 2024

Oct 31, 2024

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire

Oct 31, 2024

Oct 28, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat

Oct 28, 2024

Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance - Investing.com India

Oct 17, 2024

Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada

Oct 17, 2024

Oct 17, 2024

Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail

Oct 17, 2024

Oct 17, 2024

Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 17, 2024

Oct 14, 2024

Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily

Oct 14, 2024

Oct 10, 2024

Aerovate Therapeutics announces board member resignation - Investing.com India

Oct 10, 2024

Oct 10, 2024

Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK

Oct 10, 2024

Oct 10, 2024

Aerovate Therapeutics Board Member Maha Katabi Resigns - TipRanks

Oct 10, 2024

Oct 03, 2024

XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 03, 2024